Aon’s US$30 billion bid for Willis Towers Watson to create the world’s largest insurance broker faces a five-month long investigation after EU antitrust regulators voiced concerns that the deal may hurt competition in key markets.
The merger of the world’s second and third largest brokers would overtake world No. 1 Marsh & McLennan Companies. The deal came just as financial markets were sliding as a result of the COVID-19 crisis.
The pandemic has triggered a sharp rise in claims for insurers, on top of other challenges such as climate change, and hit their investment portfolios.
Falling valuations and companies looking to shore up business models have in turn sparked a run of deals across the insurance industry.
Aon stated it was confident of securing EU approval without having to sell any assets to allay competition concerns and that it was on track to close the deal in the first half of 2021.
The European Commission stated the deal could significantly reduce competition in markets for commercial risk brokerage services, re-insurance brokerage, and provision of retirement and health & welfare services to commercial customers.
It cited brokerage services to large multi-national customers in property and casualty, financial and professional, credit and political risk, cyber, and marine as well as customers in the space and aerospace manufacturing industry as the most affected.
Featured News
UK Probes Lindab’s Acquisition of HAS-Vent Amid Fears of Market Monopoly
Apr 28, 2024 by
CPI
Shein Faces EU Regulations Over User Data
Apr 28, 2024 by
CPI
Google Fights Back Against US Antitrust Lawsuit
Apr 28, 2024 by
CPI
US Homeland Security Establishes Blue-Ribbon Board with Tech CEOs to Advise on AI
Apr 28, 2024 by
CPI
FTC Accuses Amazon Executives of Using Disappearing Messaging Apps to Conceal Evidence
Apr 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI